<DOC>
	<DOCNO>NCT02363829</DOCNO>
	<brief_summary>Patients 18 year age old clinical stage IIA , IIB , IIIA , IIIB , IVA cervical carcinoma limit pelvis receive twice daily oral nelfinavir ( NFV ) weekly IV cisplatin combination radiosensitizers daily whole pelvic external beam intracavitary radiation brachytherapy .</brief_summary>
	<brief_title>A Study Nelfinavir Added Cisplatin Chemotherapy Concurrent With Pelvic Radiation Locally Advanced Cervical Cancer ( II-IVA )</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<criteria>All patient primary , previously untreated , histologically confirm invasive carcinoma uterine cervix ( cell type ) . Clinical stage IIA , IIB , IIIA , IIIB , IVA . A representative H &amp; E stain slide show documentation primary invasive cancer require . Patients must adequate bone marrow , renal hepatic function : Laboratory work must perform within 30 day prior start study treatment . ANC ≥ 1,500/μL ; Platelet count ≥ 100,000/μL ; Creatinine &lt; 2.0 mg/dL ; Total Bilirubin ≤ 1.5 time normal ; SGOT ≤ 3 time normal . Patients ECOG/GOG Performance Status 0 , 1 , 2 . Patients ureteral obstruction must treat stent nephrostomy tube . Patients childbearing potential must use effective form birth control . `` Patients receive oral contraceptive instruct alternate additional contraceptive measure use therapy VIRACEPT. `` Confirmed seronegative HIV status within 3 month prior start study treatment . Patients must least 18 year age . Patients must sign approve informed consent authorization permit release personal health information . Exclusion criterion Patients Stage IA , IB IVB disease . Patients known metastasis organ outside radiation field time original clinical surgical staging . Patients receive previous pelvic abdominal radiation , cytotoxic chemotherapy , previous therapy kind malignancy . Patients septicemia severe infection . Patients circumstance permit completion study require followup . Patients pregnant time diagnosis wish pregnancy termination prior initiation treatment . Patients renal abnormality , pelvic kidney , horseshoe kidney , renal transplantation , would require modification radiation field . Patients concomitant malignancy ( exception nonmelanoma skin cancer ) , ( ) evidence cancer present within last 5 year . Patients GI tract disease result inability take oral medication , malabsorption syndrome , requirement IV alimentation , prior surgical procedure affect absorption , uncontrolled inflammatory GI disease ( e.g. , Crohn 's , ulcerative colitis ) . Patients poorly control diabetes mellitus despite medication . Patients take antiarythmic agent amiodarone , quinidine , rifampin , ergot derivative ergotamine , St John 's Wort , HMGCoA reductase inhibitor lovastatin , neuroleptic pimozide , sedatives midazolam triazolam among CYP3A4 CYP2C19 substrate . Patients Phenylketonuria</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>clinical stage IIA , IIB , IIIA , IIIB , IVA</keyword>
	<keyword>invasive carcinoma</keyword>
	<keyword>uterine cervix</keyword>
</DOC>